Costa Rica MedTech Header
Gowned technicians assembling and inspecting medical devices in a clean, modern Costa Rica manufacturing lab.

Life Sciences Forum Costa Rica 2026

The Life Sciences Forum 2026, organized by CINDE, will bring together Costa Rica’s life sciences and MedTech ecosystem on Thursday, June 4, 2026, at the Costa Rica Convention Center. Returning for its 5th edition, the forum is positioned as one of the most important life sciences events in Latin America, designed to connect the full value chain and strengthen Costa Rica’s role as a leading regional hub for advanced manufacturing, medical devices, health technology, and innovation.

Under the message “Engage with the entire life sciences value chain,” this full-day event will gather executives, decision-makers, suppliers, contract manufacturers, OEMs, investors, researchers, academia, startups, service providers, and international guests. The objective is not only to bring the sector together, but to create a high-value environment for networking, business development, knowledge sharing, and long-term collaboration.

Costa Rica’s life sciences industry continues to stand out as one of the country’s strongest engines for foreign direct investment, exports, specialized employment, and global competitiveness. With more than 90 life sciences companies represented, the forum will offer attendees the opportunity to meet key players from Costa Rica’s expanding ecosystem and connect with international organizations looking to understand, invest in, or partner with the region.

The 2026 edition will focus on the next frontier of life sciences, including artificial intelligence, automation, greater specialization, advanced manufacturing, supplier development, and the evolution of global MedTech value chains. Attendees can expect keynote sessions, panels, an exhibition area, sponsor activations, one-on-one networking opportunities, and conversations with leaders shaping the future of the industry.

For professionals in manufacturing, engineering, operations, quality, regulatory affairs, research and development, business development, investment, academia, logistics, and supplier networks, the Life Sciences Forum 2026 is a valuable opportunity to understand where the sector is heading and how Costa Rica can continue building stronger capabilities across the complete life sciences value chain.

Whether you are looking to identify strategic partners, expand your presence in Costa Rica, explore new business opportunities, discover emerging technologies, or position your company within the region’s life sciences ecosystem, this forum is one of the key events to attend in 2026.

Why participate?

  • Connect with leaders across the entire life sciences and MedTech value chain
  • Meet OEMs, suppliers, contract manufacturers, service providers, investors, startups, researchers, and academia
  • Explore opportunities for business development, supplier collaboration, and regional growth
  • Learn about artificial intelligence, automation, specialization, and emerging industry trends
  • Strengthen your company’s visibility in Costa Rica’s life sciences ecosystem
  • Access a full-day event with conferences, exhibition hall, lunch, coffee breaks, cocktail, and premium networking
  • Engage with Costa Rica’s leading life sciences companies and international guests

Agenda highlights

Life Sciences Forum 2026 is a full-day experience with conferences, exhibition hall access, sponsor booths, networking spaces, lunch, coffee breaks, and a closing cocktail. CINDE planned the event as a space to engage with the full life sciences value chain, with more than 10 hours for one-on-one networking and participation from key decision-makers across Costa Rica’s life sciences hub.

Key themes announced for the 2026 edition include:

  • The next frontier in life sciences
  • Artificial intelligence applied to industry transformation
  • Automation and smart manufacturing
  • Greater specialization across the life sciences sector
  • Supplier development and value-chain integration
  • Costa Rica’s role as a leading life sciences hub in Latin America
  • Global MedTech trends and opportunities for regional growth

Event details

  • Event: Life Sciences Forum 2026
  • Organizer: CINDE
  • Date: Thursday, June 4, 2026
  • Location: Costa Rica Convention Center
  • Format: Full-day event
  • Audience: Life sciences leaders, MedTech companies, suppliers, investors, researchers, academia, startups, service providers, and ecosystem partners
  • Registration: events.cinde.org/lsf2026

Leave a Reply

Threat Modeling in MedTech: Turning Cybersecurity Regulation into Patient-Safety Evidence

TL;DR Who this guide is for This guide is for MedTech founders, product managers, systems engineers, software leads, cybersecurity engineers, QA/RA professionals, clinical engineering leaders, supplier-quality teams, and project managers. This guide moves from regulatory context to patient-safety impact, then into a practical threat-modeling workflow, a connected infusion pump example, attack modeling, DFD + STRIDE…

Managing Change in Regulated MedTech Software

🧭 TL;DR Who this article is for This article is for MedTech project managers, product managers, software leads, QA/RA, systems engineers, cybersecurity leads, and supplier-quality partners working with regulated software, SaMD and SiMD, connected devices, or hybrid medical-device programs. It is especially useful for teams trying to reconcile two pressures that often feel opposed: How…

Stakeholder Management in MedTech

Stakeholder management in MedTech is not a “soft skill.” It is part of the design-control and risk-control system that determines whether a product can be safely released, adopted, supported, and defended with objective evidence. This article is MedTech-first and experience-based. In regulated medical software, stakeholder management is not just communication. It is how expectations become…

Unpacking the Project Performance Domains in MedTech

Project performance domains are one of those concepts that sit quietly underneath everything in modern project management: they’re not a “method,” but they often determine whether the work is coherent, repeatable, and value-realizing. I’m writing this from the perspective of a program manager in high‑stakes engineering (MedTech and other regulated environments). I started learning with…

Agile in regulated medical device software: what TIR45:2023 really added

I believe in starting an Agile roadmap from an agnostic Agile perspective. I focus on the outcomes. I focus on flow. I focus on learning. I do this in any industry. I do it even more in safety-critical industries. That is why I paid close attention to the updates in AAMI TIR45:2023. This update matters.…

Prioritization tools: Pareto Analysis

Pareto Analysis is a prioritization method based on a simple observation: You don’t use Pareto to ignore the remaining issues, you use it to sequence work so the team earns the biggest satisfaction gains early. 🎯 Quick Takeaway: Pareto Analysis (the 80/20 rule) helps you focus improvement work on the small number of issues that…

Software Engineering in the Age of AI

Software Engineering in the Age of A.I. AI-assisted coding is here, and it’s improving fast, however software engineering still lives or dies by verification and validation discipline. Modern generative AI is fundamentally probabilistic, while many real systems demand behavior we can justify as provable (or at least defensible with strong objective evidence). The path forward…

Agile Progress Reporting Charts

How to read this article 🧭 TL;DR: Agile progress charts are not “status.” They’re a way to make scope volatility, flow constraints, and risk visible early enough to steer. Progress reporting in Agile Progress charts are not decoration. They are decision tools. In high-stakes engineering environments (including regulated work), “status” is cheap but predictability and…

Discover more from Costa Rica MedTech

Subscribe now to keep reading and get access to the full archive.

Continue reading